A Canadian cannabis stock moved higher Friday following a Quebec asset sale. Here’s some small stocks making big moves on Friday, July 31, 2020 (as of 4 pm EST):
Emerald Health Therapeutics, Inc. (TSXV:EMH), a Canadian cannabis stock, jumped 11% to $0.21 on Friday after announcing that it has agreed to sell its Quebec cannabis business to Quinto Resources in consideration for $21 million in cash.
As well, shares of Clean TeQ Holdings Limited (TSX:CLQ) slipped 6% to $0.17 as the metals recovery and industrial water treatment provider said it expects to realize a non-cash write down of the carrying value of its Sunrise Project and project-related assets in the amount of approximately A$180 million during its 2020 Fiscal Year.
Acasti Pharma Inc. (TSXV:ACST), meanwhile, reported that it has completed its revisions to the pre-specified Statistical Analysis Plan for the TRILOGY 2 Phase 3 trial of CaPre, and has filed it with the Food and Drug Administration (FDA). The Company added that it remains on track to report TRILOGY 2 topline data on or about August 31, 2020. Acasti Pharma stock moved up 17% to $1.01 following the announcement.
Finally, Nevada Sunrise Gold Corporation (TSXV:NEV) shares continued to move higher Friday, up 9% to $0.185 following a 26% gain on Thursday, after the junior explorer announced that drilling has begun at its 20.01% owned Kinsley Mountain Gold Project in Nevada. Joint venture partner and project operator New Placer Dome Gold Corp. (TSXV:NGLD) owns the remaining 79.9% interest.
Disclosure: Neither the author nor his family own shares in any of the companies mentioned above.
To read our full disclosure, please click on the button below:
The Content contained on this page (including any facts, views, opinions, recommendations, description of, or references to, products or securities) made available by SmallCapPower/Ubika Research is for information purposes only and is not tailored to the needs or circumstances of any particular person. Any mention of a particular security is merely a general discussion of the merits and risks associated there with and is not to be used or construed as an offer to sell, a solicitation of an offer to buy, or an endorsement, recommendation, or sponsorship of any entity or security by SmallCapPower/Ubika Research. The Reader should apply his/her own judgment in making any use of any Content, including, without limitation, the use of any information contained therein as the basis for any conclusions. The Reader bears responsibility for his/her own investment research and decisions. Before making any investment decision, it is strongly recommended that you seek outside advice from a qualified investment advisor. SmallCapPower/Ubika Research does not provide or guarantee any financial, legal, tax, or accounting advice or advice regarding the suitability, profitability, or potential value of any particular investment, security, or information source. Ubika and/or its affiliates and/or their respective officers, directors or employees may from time to time acquire, hold or sell securities and/or commodities and/or commodity futures contracts in certain underlying companies mentioned in this site and which may also be clients of Ubika’s affiliates. In such instances, Ubika and/or its affiliates and/or their respective officers, directors or employees will use all reasonable efforts to avoid engaging in activities that would lead to conflicts of interest and Ubika and/or its affiliates will use all reasonable efforts to comply with conflicts of interest disclosures and regulations to minimize the conflict.
Emerald Health Therapeutics, Inc. (TSXV:EMH), a Canadian cannabis stock, jumped 11% to $0.21 on Friday after announcing that it has agreed to sell its Quebec cannabis business to Quinto Resources in consideration for $21 million in cash.
, moved higher on Friday following a Quebec asset sale.){kind=link}